Clinical Trial Update: Phase I Vorinostat in Combination With Niacinamide and Etoposide for Lymphoid Malignancies [Phase 1]

View source ↗

Summary

A Phase I trial evaluating vorinostat in combination with niacinamide and etoposide for Hodgkin's disease and non-Hodgkin's lymphoma has completed with results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Disease
• Non-hodgkin Lymphoma

Drugs mentioned

• Etoposide (Etoposide)
• Niacinamide (nicotinamide)
• Vorinostat (vorinostat)

Snippet

Sponsor: Columbia University | Conditions: Hodgkin's Disease, Non-Hodgkin's Lymphoma | Phase 1 | Status: COMPLETED | Results posted: 2015-03-10